Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institute on Drug Abuse (NIDA) plans to establish a Center focused on educating and supporting researchers in the formal product development of new pharmacotherapeutics for substance use disorders (SUD). This Center will provide both technical and financial assistance to advance promising research concepts through initial experiments, addressing a recognized need among drug addiction researchers for formal training in product development and access to specialized expertise. The initiative encourages applicants to develop a comprehensive curriculum for SUD researchers, propose outreach and networking strategies to engage the research community, and outline infrastructure support for early-stage experimentation. Although applications are not currently being solicited, this announcement is intended to give prospective applicants ample time to form meaningful collaborations and prepare responsive proposals. Researchers with backgrounds in drug discovery and development and institutions capable of supporting such a Center are encouraged to consider applying when the formal opportunity arises. The project will be supported under relevant NIH grant authorities and federal regulations, ensuring compliance with established standards for research funding and administration. Contact information is provided for further inquiries to facilitate preparation and engagement.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institute on Drug Abuse (NIDA) seeks to advance its mission by establishing a Center that educates and supports researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics. The Center will also help advance the best concepts through initial experiments via technical and financial support. Previous NIDA-supported initiatives in early translational research have shown that drug addiction researchers are eager to acquire formal product development skills and access technical expertise and support. Prospective applicants are encouraged to: develop plans for a product development curriculum to be taught to SUD researchers, outline outreach and networking initiatives to engage the research community and recruit researchers' concepts for development within the Center, and describe the infrastructure support that may be provided for initial experiments.
Applications are not being solicited at this time. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. Investigators with expertise in the areas of drug discovery and development and institutional capacities to support such a Center are encouraged to begin to consider applying for this NOFO.Grant authorities that allow NIH to forecast this opportunity are as follows Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Part 75 and 2 CFR Part 200].
